Antibiotic Resistance: Additional Federal Actions Needed to Better Determine Magnitude and Reduce Impact
Print
Antibiotic-resistant infections can be difficult or impossible to treat.
We examined federal challenges to addressing antibiotic resistance:
Surveillance—Tracking resistant infections is tough because of reliance on sampling and voluntary reporting
Diagnostics—Lack of data on clinical outcomes impedes the development and use of antibiotic-resistance tests
New treatments—The pipeline of new antibiotics is inadequate and federal efforts haven’t fully incentivized development
Antibiotic use—Federal requirements to improve antibiotic use are mostly limited to hospitals and nursing homes
We examined federal challenges to addressing antibiotic resistance:
Surveillance—Tracking resistant infections is tough because of reliance on sampling and voluntary reporting
Diagnostics—Lack of data on clinical outcomes impedes the development and use of antibiotic-resistance tests
New treatments—The pipeline of new antibiotics is inadequate and federal efforts haven’t fully incentivized development
Antibiotic use—Federal requirements to improve antibiotic use are mostly limited to hospitals and nursing homes